Discover
BMEA
Biomea Fusion, Inc.
1.36
2 x 1.05
2 x 1.72
bid
ask
-
0.11
7.48%
2 @ 04:10 AM
1.40 +0.04 (2.94%)
| Ytd | 9.68% | |
| 1y | -20.93% |
1.32
day range
1.49
0.87
52 week range
2.99
| Open | 1.48 | Prev Close | 1.47 | Low | 1.32 | High | 1.49 | Mkt Cap | 98.33M |
| Vol | 1.38M | Avg Vol | 1.41M | EPS | -0.55 | P/E | N/A | Forward P/E | -1.21 |
| Beta | -0.43 | Short Ratio | 12.98 | Inst. Own | 64.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 1.40 | 200-d Avg | 1.44 | 1yr Est | 40.56 |
BMEA News
benzinga.com
Reported Friday, Biomea Fusion Presents ADA Data Showing Icovamenib Delivers 1.8% Placebo-Adjusted H
Translational data presented at ADA demonstrate icovamenib's potential to promote muscle preserv
benzinga.com
Biomea Fusion Partners With The University Of Leicester For Ongoing Platform Research Study Titled '
Collaboration will Assess the Potential Impact of the Combination of Icovamenib and Semaglutide on P